Word

CONDYNINE

Status

Registered

Status Code

700

Status Date

Tuesday, September 26, 2023

Serial Number

90894959

Registration Number

7172244

Registration Date

Tuesday, September 26, 2023

Mark Type

5000

Filing Date

Friday, August 20, 2021

Published for Opposition

Tuesday, March 14, 2023

Trademark Owner History

Akeso Pharmaceuticals, Inc. - Original Registrant

Classifications

5 Pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; vaccines; biochemical medicines for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; chemico-pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; biological preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia for medical purposes; hemoglobin; medicines for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia for human purposes; Drugs, namely, pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia for human purposes; hematogen for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; injectable medicinal solutions for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia

35 Retail store services and wholesale store services featuring medicines; Retail store services and wholesale stole services featuring pharmaceutical preparations; Retail store services and wholesale store services featuring sanitary preparations; Retail store services and wholesale store services featuring medical supplies; advertising and publicity services; publicity; organization of exhibitions and events for commercial or advertising purposes; marketing the goods and services of others by providing hyperlinks to websites of others; demonstration of goods; conducting market studies; business appraisals; business investigations; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; import-export agency services

42 Technological research in the field of medicines and pharmaceutical preparations; research and development of new products for others; scientific laboratory services; product quality testing; conducting technical project studies in the nature of research in the field of pharmaceutical studies; chemical research; chemistry services, namely, research in the field of chemistry; chemical analysis; biological research; bacteriological research; medical and scientific research, namely, conducting clinical trials for others; scientific research

The mark consists of the stylized word "CONDYNINE".

Trademark Events

Feb 5, 2024

Teas Change Of Correspondence Received

Feb 5, 2024

Attorney/Dom.Rep.Revoked And/Or Appointed

Feb 5, 2024

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Sep 26, 2023

Notice Of Registration Confirmation Emailed

Sep 26, 2023

Registered-Principal Register

Aug 18, 2023

1(B) Basis Deleted; Proceed To Registration

Jun 28, 2023

Notice Of Allowance Cancelled

Aug 18, 2023

Case Assigned To Intent To Use Paralegal

Jun 28, 2023

Teas Delete 1(B) Basis Received

May 9, 2023

Noa E-Mailed - Sou Required From Applicant

Mar 14, 2023

Official Gazette Publication Confirmation E-Mailed

Mar 14, 2023

Published For Opposition

Feb 22, 2023

Notification Of Notice Of Publication E-Mailed

Feb 8, 2023

Approved For Pub - Principal Register

Jan 25, 2023

Teas/Email Correspondence Entered

Jan 25, 2023

Correspondence Received In Law Office

Jan 24, 2023

Assigned To Lie

Nov 23, 2022

Teas Response To Office Action Received

May 24, 2022

Notification Of Non-Final Action E-Mailed

May 24, 2022

Non-Final Action E-Mailed

May 24, 2022

Non-Final Action Written

May 23, 2022

Assigned To Examiner

Oct 7, 2021

New Application Office Supplied Data Entered

Aug 24, 2021

New Application Entered